Podcast Episodes
Back to Search
Episode 184: Vaccines for kids, inside Operation Warp Speed, & a big biotech resignation
Can the FDA be too transparent? Who deserves credit for Operation Warp Speed? And when is a CEO worth $3 billion? We cover all that and more this wee…
5 years ago
Episode 183: Greg Zuckerman on the vaccine race, plus Biogen's troubled launch
Wall Street Journal reporter Gregory Zuckerman joins us to share some behind-the-scenes details from race to develop a Covid-19 vaccine, the subject …
5 years ago
Episode 182: The FDA star search, more booster debates, & the future of mRNA
STAT Washington correspondent Nicholas Florko joins us to provide an inside look at the eleventh-hour search for a permanent FDA commissioner. We als…
5 years ago
Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline
First, we discuss the scramble to find new leaders for the NIH and FDA, the latest online dustup involving Ginkgo Bioworks, and the growing promise o…
5 years ago
Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest
First, we welcome STAT reporter Usha Lee McFarling onto the podcast to discuss her investigation into health equity tourism — how white scholars are …
5 years, 1 month ago
Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout
First, STAT's Helen Branswell joins us to discuss the state of the Covid-19 pandemic as we head into another winter. Then, former FDA Commissioner Sc…
5 years, 1 month ago
Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial
Can prosthetic limbs feel real? Is the FDA softening under pressure? And are Rice Krispies Treats admissible in court? STAT's Gideon Gil joins us to …
5 years, 1 month ago
Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth
First, STAT's Erin Brodwin joins us to talk about Verily, Google's big-idea life sciences company that is now under pressure to produce some actual p…
5 years, 1 month ago
Episode 176: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals
Former Theranos CEO Elizabeth Holmes is finally headed to trial, and we discuss the case and why it might not be an open-and-shut conviction for pros…
5 years, 1 month ago
Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summer
First, law professor Dorit Reiss joins us to discuss what the first FDA approval of a Covid-19 vaccine means for vaccination mandates and how this wh…
5 years, 2 months ago